APR 03, 2020 6:09 PM PDT

Drug Eradicates SARS-Cov-2 in Mice

WRITTEN BY: Nouran Amin

A collaborative team of researchers joined forces to study the anti-parasitic drug, Ivermectin, and it’s role in stopping the SARS-CoV-2 virus. The studies lead to a finding that it can kill the virus in vitro within 48 hours when grown in cell culture.

"We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," says Dr. Kylie Dr Wagstaff from the Monash Biomedicine Discovery Institute.

Ivermectin is a widely available FDA-approved anti-parasitic therapeutic that has shown promise against a wide range of viruses including HIV, Dengue, Influenza and Zika virus.

Learn more about SARS-CoV-2:

"Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective -- that's the next step," Dr. Wagstaff said. "In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it's going to be a while before a vaccine is broadly available.”

How exactly does Ivermectin work on the virus? The answer to that remains unknown—however, it is believed that it may inhibit the virus actions on dampening down the host cells ability in clearing it.

"As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19," adds Dr. Leon Caly, a Senior Medical Scientist who conducts live coronavirus experiments at the Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty Institute.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 01, 2020
Drug Discovery & Development
Antidepressants Treats Lazy Eye
OCT 01, 2020
Antidepressants Treats Lazy Eye
A study published in Current Biology revealed how a therapeutic used as an antidepressant and for managing pain could tr ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
NOV 09, 2020
Drug Discovery & Development
Can Oxidants Slow Down Cellular Aging?
NOV 09, 2020
Can Oxidants Slow Down Cellular Aging?
Oxidants are reactive oxygen species known to be harmful to living organisms at high concentrations and have been linked ...
Loading Comments...